BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
7.4500
14-11月-24 15:00:12
15 分の遅延
株式
-0.1900
-2.49%
本日の幅
7.4000 - 7.7400
ISIN
N/A
ソース
NASDAQ
-
27 4 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst to Report First Quarter 2022 Financial Results on May 5
21 4 2022 06:00:52 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conference
11 4 2022 07:30:49 提供 Nasdaq GlobeNewswire
-
BioCryst Pauses Enrollment in BCX9930 Clinical Trials
08 4 2022 08:15:13 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 4 2022 06:15:42 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
03 3 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 3 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones
23 2 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
BioCryst to Report Fourth Quarter 2021 Financial Results on February 23
09 2 2022 06:00:00 提供 Nasdaq GlobeNewswire